Literature DB >> 32909246

Common combinations of medications used among oldest-old women: a population-based study over 15 years.

Kaeshaelya Thiruchelvam1,2, Julie Byles3,4, Syed Shahzad Hasan3,5, Nicholas Egan3,4, Dominic Cavenagh3,4, Therese Kairuz3,6.   

Abstract

BACKGROUND: Older people use many medications, but combinations of medications used among the oldest old (≥ 80 years) are not commonly reported. AIMS: This study aimed to determine common combinations of medications used among women aged 77-96 years and to describe characteristics associated with these combinations.
METHODS: A cohort study of older women enroled in the Australian Longitudinal Study on Women's Health over a 15-year period was used to determine combinations of medications using latent class analysis. Multinomial logistic regression was used to determine characteristics associated with these combinations.
RESULTS: The highest medication users during the study were for the cardiovascular (2003: 80.28%; 2017: 85.63%) and nervous (2003: 66.03%; 2017: 75.41%) systems. A 3-class latent model described medication use combinations: class 1: 'Cardiovascular & neurology anatomical group' (27.25%) included participants using medications of the cardiovascular and nervous systems in their later years; class 2: 'Multiple anatomical group' (16.49%) and class 3: 'Antiinfectives & multiple anatomical group' (56.27%). When compared to the reference class (class 1), the risk of participants being in class 3 was slightly higher than being in class 2 if they had > 4 general practitioner visits (RRR 2.37; 95% CI 2.08, 2.71), Department of Veterans Affairs' coverage (RRR 1.59; 95% CI 1.36, 1.86), ≥ 4 chronic diseases (RRR 3.16; 95% CI 2.56, 3.90) and were frail (RRR 1.47; 95% CI 1.27, 1.69).
CONCLUSION: Identification of combinations of medication use may provide opportunities to develop multimorbidity guidelines and target medication reviews, and may help reduce medication load for older individuals.

Entities:  

Keywords:  Ageing; Medication combinations; Medication pattern; Medication use; Older people

Mesh:

Year:  2020        PMID: 32909246     DOI: 10.1007/s40520-020-01693-y

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  11 in total

1.  Validation of the frail scale in a cohort of older Australian women.

Authors:  Derrick Lopez; Leon Flicker; Annette Dobson
Journal:  J Am Geriatr Soc       Date:  2012-01       Impact factor: 5.562

2.  Polypharmacy among inpatients aged 70 years or older in Australia.

Authors:  Ruth E Hubbard; Nancye M Peel; Ian A Scott; Jennifer H Martin; Alesha Smith; Peter I Pillans; Arjun Poudel; Leonard C Gray
Journal:  Med J Aust       Date:  2015-04-20       Impact factor: 7.738

3.  Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study.

Authors:  Nazanin Abolhassani; Julien Castioni; Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber
Journal:  Eur J Clin Pharmacol       Date:  2017-06-21       Impact factor: 2.953

4.  Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users.

Authors:  Neerav Monga; Jürgen Rehm; Benedikt Fischer; Suzanne Brissette; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Francesco Leri; Jean-Sébastien Fallu; Saira Bahl
Journal:  Drug Alcohol Depend       Date:  2006-10-17       Impact factor: 4.492

5.  Updated analysis on polypharmacy and mortality from the ESTHER study.

Authors:  Ben Schöttker; Dana Clarissa Muhlack; Liesa Katharina Hoppe; Bernd Holleczek; Hermann Brenner
Journal:  Eur J Clin Pharmacol       Date:  2018-04-06       Impact factor: 2.953

6.  Cohort Profile Update: Australian Longitudinal Study on Women's Health.

Authors:  Annette J Dobson; Richard Hockey; Wendy J Brown; Julie E Byles; Deborah J Loxton; Deirdre McLaughlin; Leigh R Tooth; Gita D Mishra
Journal:  Int J Epidemiol       Date:  2015-06-30       Impact factor: 7.196

7.  A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older.

Authors:  Tessa K Morgan; Margaret Williamson; Marie Pirotta; Kay Stewart; Stephen P Myers; Joanne Barnes
Journal:  Med J Aust       Date:  2012-01-16       Impact factor: 7.738

Review 8.  Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.

Authors:  Terri R Fried; John O'Leary; Virginia Towle; Mary K Goldstein; Mark Trentalange; Deanna K Martin
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

9.  Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity.

Authors:  Lloyd D Hughes; Marion E T McMurdo; Bruce Guthrie
Journal:  Age Ageing       Date:  2012-08-21       Impact factor: 10.668

10.  Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.

Authors:  Tyler S Bartholomew; Hansel E Tookes; Corinne Bullock; Jason Onugha; David W Forrest; Daniel J Feaster
Journal:  Int J Drug Policy       Date:  2020-03-05
View more
  1 in total

1.  Residential Medication Management Reviews and continuous polypharmacy among older Australian women.

Authors:  Kaeshaelya Thiruchelvam; Julie Byles; Syed Shahzad Hasan; Nicholas Egan; Therese Kairuz
Journal:  Int J Clin Pharm       Date:  2021-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.